So you are saying that Amarin never plans to make another regulatory submission to the US government (FDA)?
When you get expanded label on a blockbuster, you don’t claim first amendment. It’s sort of like having a legal pot store in California but selling crack out of the back because you aren’t already making oodles of cash.